7 trends tracked about this subject — the full history, oldest to newest below.
Five U.S. states joined the FTC's lawsuit against Hims & Hers on Tuesday, expanding a case that alleges the telehealth company shared sensitive health data with Meta and Snap and charged for prescriptions before provider consultations.
Hims & Hers faces financial turbulence as subscriber losses prompt a guidance cut and warning.
Eli Lilly has struck a deal allowing Hims & Hers Health to sell its obesity drugs Zepbound and Foundayo directly on its platform.
Hims & Hers faces multiple legal challenges from the FTC and the state of Utah over data privacy and subscription practices.
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The FTC files a lawsuit against Hims & Hers, targeting data sharing practices and deceptive billing allegations.
An FDA advisory panel has voted to allow the compounding of unapproved peptides, signaling a potential conflict with agency scientists.